Prevymis (letermovir) concentrate for solution for infusion - Essential to administer through sterile 0.2 micron or 0.22 micron polyethersulfone (PES) in-line filter

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Active substance
Letermovir
Therapeutic area (MeSH)
Cytomegalovirus Infections
Procedure number
II/16/G
Regulatory outcome
Variation
Human ATC code
J05

How useful was this page?

Add your rating